Literature DB >> 22512472

The loss of an electrostatic contact unique to AMPA receptor ligand binding domain 2 slows channel activation.

Sandra M Holley1, Ahmed H Ahmed, Jayasri Srinivasan, Swetha E Murthy, Gregory A Weiland, Robert E Oswald, Linda M Nowak.   

Abstract

Ligand-gated ion channels undergo conformational changes that transfer the energy of agonist binding to channel opening. Within ionotropic glutamate receptor (iGluR) subunits, this process is initiated in their bilobate ligand binding domain (LBD) where agonist binding to lobe 1 favors closure of lobe 2 around the agonist and allows formation of interlobe hydrogen bonds. AMPA receptors (GluAs) differ from other iGluRs because glutamate binding causes an aspartate-serine peptide bond in a flexible part of lobe 2 to rotate 180° (flipped conformation), allowing these residues to form cross-cleft H-bonds with tyrosine and glycine in lobe 1. This aspartate also contacts the side chain of a lysine residue in the hydrophobic core of lobe 2 by a salt bridge. We investigated how the peptide flip and electrostatic contact (D655-K660) in GluA3 contribute to receptor function by examining pharmacological and structural properties with an antagonist (CNQX), a partial agonist (kainate), and two full agonists (glutamate and quisqualate) in the wildtype and two mutant receptors. Alanine substitution decreased the agonist potency of GluA3(i)-D655A and GluA3(i)-K660A receptor channels expressed in HEK293 cells and differentially affected agonist binding affinity for isolated LBDs without changing CNQX affinity. Correlations observed in the crystal structures of the mutant LBDs included the loss of the D655-K660 electrostatic contact, agonist-dependent differences in lobe 1 and lobe 2 closure, and unflipped D(A)655-S656 bonds. Glutamate-stimulated activation was slower for both mutants, suggesting that efficient energy transfer of agonist binding within the LBD of AMPA receptors requires an intact tether between the flexible peptide flip domain and the rigid hydrophobic core of lobe 2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22512472      PMCID: PMC3353734          DOI: 10.1021/bi3001837

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Drug antagonism and pAx.

Authors:  H O SCHILD
Journal:  Pharmacol Rev       Date:  1957-06       Impact factor: 25.468

Review 2.  Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.

Authors:  Matthew R Hynd; Heather L Scott; Peter R Dodd
Journal:  Neurochem Int       Date:  2004-10       Impact factor: 3.921

Review 3.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

4.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 5.  Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

Authors:  D Colquhoun
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

6.  Probing the ligand binding domain of the GluR2 receptor by proteolysis and deletion mutagenesis defines domain boundaries and yields a crystallizable construct.

Authors:  G Q Chen; Y Sun; R Jin; E Gouaux
Journal:  Protein Sci       Date:  1998-12       Impact factor: 6.725

7.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

8.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

9.  Structure of a glutamate-receptor ligand-binding core in complex with kainate.

Authors:  N Armstrong; Y Sun; G Q Chen; E Gouaux
Journal:  Nature       Date:  1998-10-29       Impact factor: 49.962

10.  Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants.

Authors:  K M Partin; D K Patneau; M L Mayer
Journal:  Mol Pharmacol       Date:  1994-07       Impact factor: 4.436

View more
  5 in total

1.  Phosphorylation Induces Conformational Rigidity at the C-Terminal Domain of AMPA Receptors.

Authors:  Sudeshna Chatterjee; Carina Ade; Caitlin E Nurik; Nicole C Carrejo; Chayan Dutta; Vasanthi Jayaraman; Christy F Landes
Journal:  J Phys Chem B       Date:  2018-12-27       Impact factor: 2.991

2.  Configurational Preference of the Glutamate Receptor Ligand Binding Domain Dimers.

Authors:  Michael Yonkunas; Maiti Buddhadev; Jose C Flores Canales; Maria G Kurnikova
Journal:  Biophys J       Date:  2017-06-06       Impact factor: 4.033

3.  Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators.

Authors:  Mohammad Qneibi; Mohammad Hawash; Nidal Jaradat; Sosana Bdir
Journal:  Mol Neurobiol       Date:  2022-06-10       Impact factor: 5.682

4.  Noncompetitive antagonists induce cooperative AMPA receptor channel gating.

Authors:  Edward Y Shi; Christine L Yuan; Matthew T Sipple; Jayasri Srinivasan; Christopher P Ptak; Robert E Oswald; Linda M Nowak
Journal:  J Gen Physiol       Date:  2019-01-08       Impact factor: 4.086

5.  Mechanistic Understanding of the Phosphorylation-Induced Conformational Rigidity at the AMPA Receptor C-terminal Domain.

Authors:  Sudeshna Chatterjee; Chayan Dutta; Nicole C Carrejo; Christy F Landes
Journal:  ACS Omega       Date:  2019-08-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.